Your browser doesn't support javascript.
loading
Recombinant immunotoxins directed against the c-erb-2/HER2/neu oncogene product: in vitro cytotoxicity, pharmacokinetics, and in vivo efficacy studies in xenograft models.
Rosenblum, M G; Shawver, L K; Marks, J W; Brink, J; Cheung, L; Langton-Webster, B.
Affiliation
  • Rosenblum MG; Department of Bioimmunotherapy, The University of Texas M.D. Anderson Cancer Center, Houston 77030, USA.
Clin Cancer Res ; 5(4): 865-74, 1999 Apr.
Article in En | MEDLINE | ID: mdl-10213223
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Recombinant Fusion Proteins / Immunotoxins Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 1999 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Recombinant Fusion Proteins / Immunotoxins Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 1999 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos